Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?

OBJECTIVES--The objectives were to assess (a) the comparative merits of commonly used disease modifying drugs in the treatment of rheumatoid arthritis (RA) and (b) the influence of age, gender, and disease duration on the outcome of treatment. METHODS--Collected analysis (meta-analysis) was performe...

Disgrifiad llawn

Manylion Llyfryddiaeth

Cyhoeddwyd yn:	Ann Rheum Dis
Prif Awduron:	Capell, H A, Porter, D R, Madhok, R, Hunter, J A
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	BMJ Publishing Group 1993
Pynciau:	Research Article
Mynediad Ar-lein:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005066/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8100702/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.6.423
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!